Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation

Vaccine

Volumn 29, Issue 2, 2010, Pages 247-255

  Elliott, Alison M ^a,b   Mawa, Patrice A ^a   Webb, Emily L ^b   Nampijja, Margaret ^a   Lyadda, Nancy ^c   Bukusuba, Joseph ^a   Kizza, Moses ^a   Namujju, Proscovia B ^a,d   Nabulime, Juliet ^a   Ndibazza, Juliet ^a   Muwanga, Moses ^c   Whitworth, James A G ^a,b,e  

^a MRC   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Entebbe Hospital   (Uganda)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

BCG; Immunisation; Tetanus

Indexed keywords

ALBENDAZOLE; BCG VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; MEASLES VACCINE; NEVIRAPINE; PRAZIQUANTEL; PYRIMETHAMINE; SULFADOXINE; TETANUS TOXOID;

ARTICLE; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HAEMOPHILUS INFECTION; HELMINTHIASIS; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALARIA; MANSONELLA PERSTANS; MANSONELLIASIS; MEASLES; MEASLES VACCINATION; MIXED INFECTION; NONHUMAN; PERTUSSIS; POLIOMYELITIS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR; SINGLE DRUG DOSE; TETANUS; TUBERCULOSIS;

ADULT; ANTIBODIES, BACTERIAL; BCG VACCINE; COHORT STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTES; MALARIA; MALE; MANSONELLIASIS; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; TETANUS TOXOID; UGANDA;

EID: 78649690326     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.047     Document Type: Article

References (52)

1. Labeaud A.D., Malhotra I., King M.J., King C.L., King C.H. Do antenatal parasite infections devalue childhood vaccination?. PLoS Negl Trop Dis 2009, 3(5):e442.
2. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995, 96(1 Pt 1):29-35.
3. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346(8986):1339-1345.
4. WHO. Global tuberculosis control - epidemiology, strategy, financing. WHO/HTM/TB/2009411; 2009.
5. Beresford B., Sadoff J.C. Update on research and development pipeline: tuberculosis vaccines. Clin Infect Dis 2010, 50(Suppl. 3):S178-S183.
6. Packe G.E., Innes J.A. Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child 1988, 63(3):277-281.
7. Rodrigues L.C., Noel Gill O., Smith P.G. BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England. J Epidemiol Community Health 1991, 45(1):78-80.
8. Black G.F., Weir R.E., Floyd S., Bliss L., Warndorff D.K., Crampin A.C., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002, 359(9315):1393-1401.
9. Weir R.E., Black G.F., Nazareth B., Floyd S., Stenson S., Stanley C., et al. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to Bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol 2006, 146(3):390-399.
10. Lalor M.K., Ben-Smith A., Gorak-Stolinska P., Weir R.E., Floyd S., Blitz R., et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J Infect Dis 2009, 199(6):795-800.
11. Bentwich Z., Kalinkovich A., Weisman Z., Borkow G., Beyers N., Beyers A.D. Can eradication of helminthic infections change the face of AIDS and tuberculosis?. Immunol Today 1999, 20(11):485-487.
12. van Riet E., Hartgers F.C., Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007, 212(6):475-490.
13. Elias D., Akuffo H., Pawlowski A., Haile M., Schon T., Britton S. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 2005, 23(11):1326-1334.
14. Elias D., Akuffo H., Thors C., Pawlowski A., Britton S. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol 2005, 139(3):398-404.
15. Fletcher H.A. Correlates of immune protection from tuberculosis. Curr Mol Med 2007, 7(3):319-325.
16. Pearlman E., Kazura J.W., Hazlett F.E., Boom W.H. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol 1993, 151(9):4857-4864.
17. Elias D., Wolday D., Akuffo H., Petros B., Bronner U., Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after Bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 2001, 123(2):219-225.
18. Malhotra I., Mungai P., Wamachi A., Kioko J., Ouma J.H., Kazura J.W., et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999, 162(11):6843-6848.
19. Elliott A.M., Kizza M., Quigley M.A., Ndibazza J., Nampijja M., Muhangi L., et al. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]. Clin Trials 2007, 4(1):42-57.
20. Webb EL, Mawa PA, Ndibazza J, Kizito D, Namatovu A, Kyosiimire-Lugemwa J, et al. The impact of single-dose anthelminthic treatment during the second or third trimester of pregnancy on the infant response to immunisation and on susceptibility to infectious diseases in infancy: results of a randomised double-blinded placebo-controlled trial. Lancet; in press.
21. Guay L.A., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354(9181):795-802.
22. Muhangi L., Woodburn P., Omara M., Omoding N., Kizito D., Mpairwe H., et al. Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda. Trans R Soc Trop Med Hyg 2007, 101(9):899-907.
23. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972, 14(6):397-400.
24. Helminths F.J. Mackie & McCartney, practical medical microbiology 1996, Churchill Livingstone, Edinburgh. J.G. Collee, A. Fraser, B. Marmion, A. Simmons (Eds.).
25. Melrose W.D., Turner P.F., Pisters P., Turner B. An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg 2000, 94(2):176.
26. Elliott A.M., Hurst T.J., Balyeku M.N., Quigley M.A., Kaleebu P., French N., et al. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 1999, 3(3):239-247.
27. WHO WHO anthro, version 3 2009.
28. Joseph S., Jones F.M., Kimani G., Mwatha J.K., Kamau T., Kazibwe F., et al. Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens. Infect Immun 2004, 72(2):728-734.
29. McGuinness D., Bennett S., Riley E. Statistical analysis of highly skewed immune response data. J Immunol Methods 1997, 201(1):99-114.
30. Weir R.E., Brennan P.J., Butlin C.R., Dockrell H.M. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin Exp Immunol 1999, 116(2):263-269.
31. Woodburn P.W., Muhangi L., Hillier S., Ndibazza J., Namujju P.B., Kizza M., et al. Risk factors for helminth, malaria, and HIV Infection in pregnancy in Entebbe, Uganda. PLoS Negl Trop Dis 2009, 3(6):e473.
32. Asio S.M., Simonsen P.E., Onapa A.W. Mansonella perstans filariasis in Uganda: patterns of microfilaraemia and clinical manifestations in two endemic communities. Trans R Soc Trop Med Hyg 2009, 103(3):266-273.
33. Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop. 2010, Feb 10 [Epub ahead of print], doi:10.1016/j.actatropica.2010.01.014.
34. Cooper P.J., Espinel I., Paredes W., Guderian R.H., Nutman T.B. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 1998, 178(4):1133-1138.
35. Nookala S., Srinivasan S., Kaliraj P., Narayanan R.B., Nutman T.B. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 2004, 72(5):2598-2604.
36. Elliott A.M., Mpairwe H., Quigley M.A., Nampijja M., Muhangi L., Oweka-Onyee J., et al. Helminth infection during pregnancy and development of infantile eczema. JAMA 2005, 294(16):2032-2034.
37. Mpairwe H., Webb E., Muhangi L., Ndibazza J., Tumusiime J., Rodrigues L., et al. Effects of treatment of helminths with albendazole and praziquantel in pregnancy on the incidence of allergy in the first year of life: trial results. Allergy 2009, 64(Suppl. 90):92.
38. Elliott A.M., Namujju P.B., Mawa P.A., Quigley M.A., Nampijja M., Nkurunziza P.M., et al. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guerin (BCG) immunisation [ISRCTN32849447]. BMC Infect Dis 2005, 5:115.
39. Knopp S., Rinaldi L., Khamis I.S., Stothard J.R., Rollinson D., Maurelli M.P., et al. A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections. Trans R Soc Trop Med Hyg 2009, 103(4):347-354.
40. Utzinger J., Booth M., N'Goran E.K., Muller I., Tanner M., Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001, 122(Pt 5):537-544.
41. Gill T.J., Repetti C.F., Metlay L.A., Rabin B.S., Taylor F.H., Thompson D.S., et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983, 72(3):987-996.
42. Malek A. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 2003, 21(24):3362-3364.
43. May K., Grube M., Malhotra I., Long C.A., Singh S., Mandaliya K., et al. Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PLoS One 2009, 4(11):e7986.
44. Schneider H., Miller R.K. Receptor-mediated uptake and transport of macromolecules in the human placenta. Int J Dev Biol 2010, 54(2-3):367-375.
45. de Moraes-Pinto M.I., Verhoeff F., Chimsuku L., Milligan P.J., Wesumperuma L., Broadhead R.L., et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998, 79(3):F202-F205.
46. Scott S., Cumberland P., Shulman C.E., Cousens S., Cohen B.J., Brown D.W., et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005, 191(11):1854-1860.
47. Malhotra I., Ouma J., Wamachi A., Kioko J., Mungai P., Omollo A., et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997, 99(7):1759-1766.
48. Rahman M.J., Degano I.R., Singh M., Fernandez C. Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model. PLoS One 2010, 5(3):e9699.
49. Aaby P., Jensen H., Rodrigues A., Garly M.L., Benn C.S., Lisse I.M., et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol 2004, 33:367-373.
50. Rook G.A., Hernandez-Pando R., Zumla A. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?. J Infect Dis 2009, 199(5):613-618.
51. Higgins D.M., Sanchez-Campillo J., Rosas-Taraco A.G., Lee E.J., Orme I.M., Gonzalez-Juarrero M. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2009, 89(2):149-157.
52. Dietz V., Galazka A., van Loon F., Cochi S. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ 1997, 75(1):81-93.